Dr. Fichtel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
155 E Sonterra Blvd
Ste 200
San Antonio, TX 78258Phone+1 210-593-5700Fax+1 210-593-2664
Education & Training
Baylor University Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1996- Baylor University Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Texas Southwestern Medical SchoolClass of 1991
Certifications & Licensure
TX State Medical License 1992 - 2026- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 23 citationsHypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study.Andrew Brenner, Richard Zuniga, Jessica D Sun, John Floyd, Charles P. Hart
Neuro-Oncology. 2018-08-02 - 152 citationsLiver transplant-associated graft-versus-host disease.Douglas M. Smith, Edward Agura, George J. Netto, Robert H. Collins, Marlon F. Levy
Transplantation. 2003-01-15 - 27 citationsPhase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastomaAndrew Brenner, John Floyd, Lisa Fichtel, Joel E. Michalek, Kunal P. Kanakia
Scientific Reports. 2021-01-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
